{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:27:40Z","timestamp":1787138860240,"version":"build-2736575974"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The fallopian tube (FT) is increasingly recognized as the origin of high-grade serous ovarian cancer (HGSOC), yet its immune landscape remains poorly understood. Here, we employ single-cell RNA sequencing and paired T-cell receptor sequencing to profile tissue-resident memory-like T cells (TRML) from patient-derived matched non-cancerous FT, metastatic tumors, and peripheral blood. We identify substantial clonal and functional overlap (18.4%) between FT-derived and tumor-infiltrating TRMLs, exceeding that of circulating T cells. Shared clonotypes are preferentially enriched in exhausted CD8+ subsets, including a previously uncharacterized SIK3-high subset linked to epigenetic plasticity and metabolic adaptation. Functionally, FT-derived TRMLs recognize autologous tumor antigens, showing strong interferon-\u03b3 (IFN-\u03b3) responses and CD137 upregulation in organoid coculture assays, supporting a role in early immune surveillance. Notably, FT TRMLs exhibit lower exhaustion than tumor counterparts, suggesting therapeutic potential. These findings reveal a precursor immune surveillance network in the FT and support leveraging FT-resident T cells for cancer immunotherapy and prevention.<\/jats:p>","DOI":"10.1038\/s41467-026-74599-4","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:34:25Z","timestamp":1783960465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic analysis of tissue-resident memory T cells of the fallopian tube reveals a precursor immune surveillance network for ovarian cancer prevention"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-0952-494X","authenticated-orcid":false,"given":"Luyao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breeshey","family":"Roskams-Hieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosheen","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Nulsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9681-2190","authenticated-orcid":false,"given":"Lena","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Ahmed-Ebbiary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8138-2981","authenticated-orcid":false,"given":"Aws","family":"Al-deka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Artibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3293-5321","authenticated-orcid":false,"given":"Hooman","family":"Soleymani Majd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7615-8523","authenticated-orcid":false,"given":"Christopher","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9084-7178","authenticated-orcid":false,"given":"Nancy","family":"Zaarour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6509-2581","authenticated-orcid":false,"given":"Ahmed Ashour","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"74599_CR1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccr.2013.10.013","volume":"24","author":"R Perets","year":"2013","unstructured":"Perets, R. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 24, 751\u2013765 (2013).","journal-title":"Cancer Cell"},{"key":"74599_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/path.2091","volume":"211","author":"Y Lee","year":"2007","unstructured":"Lee, Y. et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J. Pathol. 211, 26\u201335 (2007).","journal-title":"J. Pathol."},{"key":"74599_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","volume":"30","author":"F Medeiros","year":"2006","unstructured":"Medeiros, F. et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am. J. Surg. Pathol. 30, 230\u2013236 (2006).","journal-title":"Am. J. Surg. Pathol."},{"key":"74599_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nrc3144","volume":"11","author":"S Vaughan","year":"2011","unstructured":"Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer 11, 719\u2013725 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"74599_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00962-1","volume":"8","author":"SI Labidi-Galy","year":"2017","unstructured":"Labidi-Galy, S. I. et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nat. Commun. 8, 1093 (2017).","journal-title":"Nat. Commun."},{"key":"74599_CR6","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1158\/2159-8290.CD-24-1366","volume":"15","author":"T Kader","year":"2024","unstructured":"Kader, T. et al. Multimodal Spatial Profiling Reveals Immune Suppression and Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma. Cancer Discov. 15, 1180\u20131202 (2024).","journal-title":"Cancer Discov."},{"key":"74599_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","volume":"4","author":"X Zheng","year":"2023","unstructured":"Zheng, X. et al. Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat. Cancer 4, 1138\u20131156 (2023).","journal-title":"Nat. Cancer"},{"key":"74599_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3233\/CBM-190528","volume":"26","author":"DW Gutkin","year":"2019","unstructured":"Gutkin, D. W. et al. Novel protein and immune response markers of human serous tubal intraepithelial carcinoma of the ovary. Cancer Biomark. 26, 471\u2013479 (2019).","journal-title":"Cancer Biomark."},{"key":"74599_CR9","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-023-06165-5","volume":"14","author":"M Wisztorski","year":"2023","unstructured":"Wisztorski, M. et al. Fallopian tube lesions as potential precursors of early ovarian cancer: a comprehensive proteomic analysis. Cell Death Dis. 14, 644 (2023).","journal-title":"Cell Death Dis."},{"key":"74599_CR10","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","volume":"42","author":"IP MacFawn","year":"2024","unstructured":"MacFawn, I. P. et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell 42, 1864\u20131881 e1865 (2024).","journal-title":"Cancer Cell"},{"key":"74599_CR11","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1038\/s41590-024-01943-5","volume":"25","author":"CY Yeh","year":"2024","unstructured":"Yeh, C. Y. et al. Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer. Nat. Immunol. 25, 1943 (2024).","journal-title":"Nat. Immunol."},{"key":"74599_CR12","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato, E. et al. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc. Natl. Acad. Sci. USA 102, 18538\u201318543 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74599_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13116-2","volume":"10","author":"S Zhang","year":"2019","unstructured":"Zhang, S. et al. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Nat. Commun. 10, 5367 (2019).","journal-title":"Nat. Commun."},{"key":"74599_CR14","doi-asserted-by":"crossref","unstructured":"Varga, A. et al. Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: Interim results from a phase Ib study. Am. Soc. Clin. Oncol. 33, 5510 (2015).","DOI":"10.1200\/jco.2015.33.15_suppl.5510"},{"key":"74599_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.coi.2005.01.001","volume":"17","author":"V Revaz","year":"2005","unstructured":"Revaz, V. & Nardelli-Haefliger, D. The importance of mucosal immunity in defense against epithelial cancers. Curr. Opin. Immunol. 17, 175\u2013179 (2005).","journal-title":"Curr. Opin. Immunol."},{"key":"74599_CR16","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.it.2019.06.002","volume":"40","author":"SL Park","year":"2019","unstructured":"Park, S. L., Gebhardt, T. & Mackay, L. K. Tissue-resident memory T cells in cancer immunosurveillance. Trends Immunol. 40, 735\u2013747 (2019).","journal-title":"Trends Immunol."},{"key":"74599_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature10851","volume":"483","author":"X Jiang","year":"2012","unstructured":"Jiang, X. et al. Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 483, 227\u2013231 (2012).","journal-title":"Nature"},{"key":"74599_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.ccell.2021.03.007","volume":"39","author":"C Krishna","year":"2021","unstructured":"Krishna, C. et al. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell 39, 662\u2013677 e666 (2021).","journal-title":"Cancer Cell"},{"key":"74599_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2022.04.008","volume":"40","author":"T Tsuji","year":"2022","unstructured":"Tsuji, T., Matsuzaki, J. & Odunsi, K. Tissue residency of memory CD8(+) T cells matters in shaping immunogenicity of ovarian cancer. Cancer Cell 40, 452\u2013454 (2022).","journal-title":"Cancer Cell"},{"key":"74599_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccell.2022.03.008","volume":"40","author":"CM Anadon","year":"2022","unstructured":"Anadon, C. M. et al. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells. Cancer Cell 40, 545\u2013557 e513 (2022).","journal-title":"Cancer Cell"},{"key":"74599_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1158\/2326-6066.CIR-19-0554","volume":"8","author":"M Abd Hamid","year":"2020","unstructured":"Abd Hamid, M. et al. Self-Maintaining CD103(+) Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses. Cancer Immunol. Res 8, 203\u2013216 (2020).","journal-title":"Cancer Immunol. Res"},{"key":"74599_CR22","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1073\/pnas.1202288109","volume":"109","author":"LK Mackay","year":"2012","unstructured":"Mackay, L. K. et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc. Natl. Acad. Sci. USA 109, 7037\u20137042 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74599_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102338","volume":"83","author":"DE Ramirez","year":"2023","unstructured":"Ramirez, D. E., Mohamed, A., Huang, Y. H. & Turk, M. J. In the right place at the right time: tissue-resident memory T cells in immunity to cancer. Curr. Opin. Immunol. 83, 102338 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"74599_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/372190a0","volume":"372","author":"KL Cepek","year":"1994","unstructured":"Cepek, K. L. et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372, 190\u2013193 (1994).","journal-title":"Nature"},{"key":"74599_CR25","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-018-0812-9","volume":"565","author":"SL Park","year":"2019","unstructured":"Park, S. L. et al. Tissue-resident memory CD8(+) T cells promote melanoma-immune equilibrium in skin. Nature 565, 366\u2013371 (2019).","journal-title":"Nature"},{"key":"74599_CR26","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1158\/2326-6066.CIR-18-0517","volume":"7","author":"HH Workel","year":"2019","unstructured":"Workel, H. H. et al. A Transcriptionally Distinct CXCL13(+)CD103(+)CD8(+) T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer. Cancer Immunol. Res 7, 784\u2013796 (2019).","journal-title":"Cancer Immunol. Res"},{"key":"74599_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/cr.2009.139","volume":"20","author":"JR Dunkelberger","year":"2010","unstructured":"Dunkelberger, J. R. & Song, W. C. Complement and its role in innate and adaptive immune responses. Cell Res 20, 34\u201350 (2010).","journal-title":"Cell Res"},{"key":"74599_CR28","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell 169, 1342\u20131356 e1316 (2017).","journal-title":"Cell"},{"key":"74599_CR29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/s41590-023-01575-1","volume":"24","author":"LC Garner","year":"2023","unstructured":"Garner, L. C. et al. Single-cell analysis of human MAIT cell transcriptional, functional and clonal diversity. Nat. Immunol. 24, 1565\u20131578 (2023).","journal-title":"Nat. Immunol."},{"key":"74599_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn8531","volume":"8","author":"S Chandra","year":"2023","unstructured":"Chandra, S. et al. Transcriptomes and metabolism define mouse and human MAIT cell populations. Sci. Immunol. 8, eabn8531 (2023).","journal-title":"Sci. Immunol."},{"key":"74599_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature01433","volume":"422","author":"E Treiner","year":"2003","unstructured":"Treiner, E. et al. Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1. Nature 422, 164\u2013169 (2003).","journal-title":"Nature"},{"key":"74599_CR32","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1093\/bioinformatics\/btac582","volume":"38","author":"B Phipson","year":"2022","unstructured":"Phipson, B. et al. propeller: testing for differences in cell type proportions in single cell data. Bioinformatics 38, 4720\u20134726 (2022).","journal-title":"Bioinformatics"},{"key":"74599_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ccell.2020.01.003","volume":"37","author":"Z Hu","year":"2020","unstructured":"Hu, Z. et al. The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells. Cancer Cell 37, 226\u2013242 e227 (2020).","journal-title":"Cancer Cell"},{"key":"74599_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh9562","volume":"15","author":"Z Meng","year":"2023","unstructured":"Meng, Z. et al. Transcriptome-based identification of tumor-reactive and bystander CD8(+) T cell receptor clonotypes in human pancreatic cancer. Sci. Transl. Med 15, eadh9562 (2023).","journal-title":"Sci. Transl. Med"},{"key":"74599_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 (2021).","journal-title":"Nature"},{"key":"74599_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun, Y. et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell 184, 404\u2013421 e416 (2021).","journal-title":"Cell"},{"key":"74599_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41392-020-00265-w","volume":"5","author":"Z Sun","year":"2020","unstructured":"Sun, Z., Jiang, Q., Li, J. & Guo, J. The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis. Signal Transduct. Target Ther. 5, 150 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"74599_CR38","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.4049\/jimmunol.1501896","volume":"196","author":"H Wei","year":"2016","unstructured":"Wei, H. et al. Cutting edge: Foxp1 controls naive CD8+ T cell quiescence by simultaneously repressing key pathways in cellular metabolism and cell cycle progression. J. Immunol. 196, 3537\u20133541 (2016).","journal-title":"J. Immunol."},{"key":"74599_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.immuni.2014.08.012","volume":"41","author":"TL Stephen","year":"2014","unstructured":"Stephen, T. L. et al. Transforming growth factor beta-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression. Immunity 41, 427\u2013439 (2014).","journal-title":"Immunity"},{"key":"74599_CR40","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s43018-021-00292-8","volume":"3","author":"B Liu","year":"2022","unstructured":"Liu, B. et al. Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer. Nat. Cancer 3, 108\u2013121 (2022).","journal-title":"Nat. Cancer"},{"key":"74599_CR41","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41591-018-0057-z","volume":"24","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. et al. A transcriptionally and functionally distinct PD-1(+) CD8(+) T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade. Nat. Med 24, 994\u20131004 (2018).","journal-title":"Nat. Med"},{"key":"74599_CR42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun, A. M., Thommen, D. S. & Schumacher, T. N. CD8(+) T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer 20, 218\u2013232 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"74599_CR43","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ccell.2022.03.005","volume":"40","author":"C Zheng","year":"2022","unstructured":"Zheng, C. et al. Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers. Cancer Cell 40, 410\u2013423 e417 (2022).","journal-title":"Cancer Cell"},{"key":"74599_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","volume":"40","author":"K-i Hanada","year":"2022","unstructured":"Hanada, K. -i et al. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers. Cancer Cell 40, 479\u2013493.e476 (2022).","journal-title":"Cancer Cell"},{"key":"74599_CR45","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ccell.2022.03.006","volume":"40","author":"JR Veatch","year":"2022","unstructured":"Veatch, J. R. et al. Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function. Cancer Cell 40, 393\u2013409.e399 (2022).","journal-title":"Cancer Cell"},{"key":"74599_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00986-0","volume":"11","author":"M Nefla","year":"2021","unstructured":"Nefla, M., Darling, N. J., van Gijsel Bonnello, M., Cohen, P. & Arthur, J. S. C. Salt inducible kinases 2 and 3 are required for thymic T cell development. Sci. Rep. 11, 21550 (2021).","journal-title":"Sci. Rep."},{"key":"74599_CR47","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1074\/jbc.M113.456996","volume":"288","author":"DR Walkinshaw","year":"2013","unstructured":"Walkinshaw, D. R. et al. The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases. J. Biol. Chem. 288, 9345\u20139362 (2013).","journal-title":"J. Biol. Chem."},{"key":"74599_CR48","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).","journal-title":"Science"},{"key":"74599_CR49","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519\u2013530 (1927).","journal-title":"J. Gen. Physiol."},{"key":"74599_CR50","first-page":"9950","volume":"13","author":"C Nantasupha","year":"2021","unstructured":"Nantasupha, C., Thonusin, C., Charoenkwan, K., Chattipakorn, S. & Chattipakorn, N. Metabolic reprogramming in epithelial ovarian cancer. Am. J. Transl. Res 13, 9950\u20139973 (2021).","journal-title":"Am. J. Transl. Res"},{"key":"74599_CR51","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498\u20131503 (2011).","journal-title":"Nat. Med"},{"key":"74599_CR52","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","volume":"375","author":"FJ Lowery","year":"2022","unstructured":"Lowery, F. J. et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science 375, 877\u2013884 (2022).","journal-title":"Science"},{"key":"74599_CR53","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med 25, 1251\u20131259 (2019).","journal-title":"Nat. Med"},{"key":"74599_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216741","volume":"588","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Antigen\/HLA-agnostic strategies for characterizing tumor-responsive T cell receptors in PDAC patients via single-cell sequencing and autologous organoid application. Cancer Lett. 588, 216741 (2024).","journal-title":"Cancer Lett."},{"key":"74599_CR55","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.ccell.2023.11.005","volume":"41","author":"R Yossef","year":"2023","unstructured":"Yossef, R. et al. Phenotypic signatures of circulating neoantigen-reactive CD8(+) T cells in patients with metastatic cancers. Cancer Cell 41, 2154\u20132165 e2155 (2023).","journal-title":"Cancer Cell"},{"key":"74599_CR56","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/00002371-200307000-00005","volume":"26","author":"ME Dudley","year":"2003","unstructured":"Dudley, M. E., Wunderlich, J. R., Shelton, T. E., Even, J. & Rosenberg, S. A. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients. J. Immunother. 26, 332\u2013342 (2003).","journal-title":"J. Immunother."},{"key":"74599_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/08830180902978120","volume":"28","author":"F Zhou","year":"2009","unstructured":"Zhou, F. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation. Int Rev. Immunol. 28, 239\u2013260 (2009).","journal-title":"Int Rev. Immunol."},{"key":"74599_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1385781","volume":"15","author":"R Reschke","year":"2024","unstructured":"Reschke, R., Deitert, B., Enk, A. H. & Hassel, J. C. The role of tissue-resident memory T cells as mediators for response and toxicity in immunotherapy-treated melanoma-two sides of the same coin? Front Immunol. 15, 1385781 (2024).","journal-title":"Front Immunol."},{"key":"74599_CR59","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/cells10102700","volume":"10","author":"F Hofer","year":"2021","unstructured":"Hofer, F. et al. A complex metabolic network confers immunosuppressive functions to myeloid-derived suppressor cells (MDSCs) within the tumour microenvironment. Cells 10, 2700 (2021).","journal-title":"Cells"},{"key":"74599_CR60","doi-asserted-by":"publisher","first-page":"e007815","DOI":"10.1136\/jitc-2023-007815","volume":"12","author":"SE Stanton","year":"2024","unstructured":"Stanton, S. E., Castle, P. E., Finn, O. J., Sei, S. & Emens, L. A. Advances and challenges in cancer immunoprevention and immune interception. J. Immunother. Cancer 12, e007815 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"74599_CR61","doi-asserted-by":"publisher","first-page":"e146471","DOI":"10.1172\/JCI146471","volume":"132","author":"Z Lu","year":"2022","unstructured":"Lu, Z. et al. SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers. J. Clin. Invest 132, e146471 (2022).","journal-title":"J. Clin. Invest"},{"key":"74599_CR62","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ccell.2016.06.020","volume":"30","author":"F Miranda","year":"2016","unstructured":"Miranda, F. et al. Salt-Inducible Kinase 2 Couples Ovarian Cancer Cell Metabolism with Survival at the Adipocyte-Rich Metastatic Niche. Cancer Cell 30, 273\u2013289 (2016).","journal-title":"Cancer Cell"},{"key":"74599_CR63","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1158\/1078-0432.CCR-16-1562","volume":"23","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. A novel compound ARN-3236 inhibits salt-inducible kinase 2 and sensitizes ovarian cancer cell lines and xenografts to paclitaxel. Clin. Cancer Res 23, 1945\u20131954 (2017).","journal-title":"Clin. Cancer Res"},{"key":"74599_CR64","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ccr.2010.06.018","volume":"18","author":"AA Ahmed","year":"2010","unstructured":"Ahmed, A. A. et al. SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer. Cancer Cell 18, 109\u2013121 (2010).","journal-title":"Cancer Cell"},{"key":"74599_CR65","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41577-018-0110-7","volume":"19","author":"M Trebak","year":"2019","unstructured":"Trebak, M. & Kinet, J. P. Calcium signalling in T cells. Nat. Rev. Immunol. 19, 154\u2013169 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"74599_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41422-020-0337-2","volume":"30","author":"YR Murciano-Goroff","year":"2020","unstructured":"Murciano-Goroff, Y. R., Warner, A. B. & Wolchok, J. D. The future of cancer immunotherapy: microenvironment-targeting combinations. Cell Res 30, 507\u2013519 (2020).","journal-title":"Cell Res"},{"key":"74599_CR67","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.ccell.2024.11.005","volume":"42","author":"IM Launonen","year":"2024","unstructured":"Launonen, I. M. et al. Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer. Cancer Cell 42, 2045\u20132063 e2010 (2024).","journal-title":"Cancer Cell"},{"key":"74599_CR68","doi-asserted-by":"publisher","first-page":"e122311","DOI":"10.1172\/jci.insight.122311","volume":"4","author":"KL Singel","year":"2019","unstructured":"Singel, K. L. et al. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment. JCI Insight 4, e122311 (2019).","journal-title":"JCI Insight"},{"key":"74599_CR69","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41571-023-00819-1","volume":"20","author":"AC Veneziani","year":"2023","unstructured":"Veneziani, A. C. et al. Heterogeneity and treatment landscape of ovarian carcinoma. Nat. Rev. Clin. Oncol. 20, 820\u2013842 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"74599_CR70","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05496-1","volume":"612","author":"I Vazquez-Garcia","year":"2022","unstructured":"Vazquez-Garcia, I. et al. Ovarian cancer mutational processes drive site-specific immune evasion. Nature 612, 778\u2013786 (2022).","journal-title":"Nature"},{"key":"74599_CR71","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"AM Patch","year":"2015","unstructured":"Patch, A. M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"74599_CR72","doi-asserted-by":"publisher","first-page":"eabd5778","DOI":"10.1126\/sciimmunol.abd5778","volume":"6","author":"P Gueguen","year":"2021","unstructured":"Gueguen, P. et al. Contribution of resident and circulating precursors to tumor-infiltrating CD8(+) T cell populations in lung cancer. Sci. Immunol. 6, eabd5778 (2021).","journal-title":"Sci. Immunol."},{"key":"74599_CR73","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med 25, 838\u2013849 (2019).","journal-title":"Nat. Med"},{"key":"74599_CR74","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1158\/0008-5472.CAN-23-3007","volume":"84","author":"JD Joy","year":"2024","unstructured":"Joy, J. D. et al. Human 3D Ovarian Cancer Models Reveal Malignant Cell-Intrinsic and -Extrinsic Factors That Influence CAR T-cell Activity. Cancer Res 84, 2432\u20132449 (2024).","journal-title":"Cancer Res"},{"key":"74599_CR75","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/CJI.0b013e31824e801f","volume":"35","author":"J Jin","year":"2012","unstructured":"Jin, J. et al. Simplified method of the growth of human tumor infiltrating lymphocytes in gas-permeable flasks to numbers needed for patient treatment. J. Immunother. 35, 283\u2013292 (2012).","journal-title":"J. Immunother."},{"key":"74599_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110400","volume":"97","author":"S Padmanabhan","year":"2022","unstructured":"Padmanabhan, S., Gaire, B., Zou, Y., Uddin, M. M. & Vancurova, I. IFNgamma-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling. Cell Signal 97, 110400 (2022).","journal-title":"Cell Signal"},{"key":"74599_CR77","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra, K. K. et al. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids. Cell 174, 1586\u20131598 e1512 (2018).","journal-title":"Cell"},{"key":"74599_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"74599_CR79","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 e3529 (2021).","journal-title":"Cell"},{"key":"74599_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giaa151","volume":"9","author":"MD Young","year":"2020","unstructured":"Young, M. D. & Behjati, S. SoupX removes ambient RNA contamination from droplet-based single-cell RNA sequencing data. Gigascience 9, giaa151 (2020).","journal-title":"Gigascience"},{"key":"74599_CR81","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M. & Gartner, Z. J. DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst. 8, 329\u2013337 e324 (2019).","journal-title":"Cell Syst."},{"key":"74599_CR82","doi-asserted-by":"publisher","first-page":"47","DOI":"10.12688\/f1000research.22139.1","volume":"9","author":"N Borcherding","year":"2020","unstructured":"Borcherding, N., Bormann, N. L. & Kraus, G. scRepertoire: An R-based toolkit for single-cell immune receptor analysis. F1000Res 9, 47 (2020).","journal-title":"F1000Res"},{"key":"74599_CR83","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"74599_CR84","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nmeth.4150","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Single-cell mRNA quantification and differential analysis with Census. Nat. Methods 14, 309\u2013315 (2017).","journal-title":"Nat. Methods"},{"key":"74599_CR85","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu, X. et al. Reversed graph embedding resolves complex single-cell trajectories. Nat. Methods 14, 979\u2013982 (2017).","journal-title":"Nat. Methods"},{"key":"74599_CR86","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao, J. et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 566, 496\u2013502 (2019).","journal-title":"Nature"},{"key":"74599_CR87","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"74599_CR88","doi-asserted-by":"publisher","first-page":"e55207","DOI":"10.7554\/eLife.55207","volume":"9","author":"M KaramiNejadRanjbar","year":"2020","unstructured":"KaramiNejadRanjbar, M. et al. A highly accurate platform for clone-specific mutation discovery enables the study of active mutational processes. Elife 9, e55207 (2020).","journal-title":"Elife"},{"key":"74599_CR89","doi-asserted-by":"crossref","unstructured":"Vasimuddin, M., Misra, S., Li, H., and Aluru, S. (2019). Efficient Architecture-Aware Acceleration of BWA-MEM for Multicore Systems. 2019 IEEE International Parallel and Distributed Processing Symposium (IPDPS). IEEE Computer Society.","DOI":"10.1109\/IPDPS.2019.00041"},{"key":"74599_CR90","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/bioinformatics\/btv098","volume":"31","author":"A Tarasov","year":"2015","unstructured":"Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032\u20132034 (2015).","journal-title":"Bioinformatics"},{"key":"74599_CR91","unstructured":"van der Auwera, G., and O\u2019Connor, B. D. (2020). Genomics in the Cloud: Using Docker, GATK, and WDL in Terra (O\u2019Reilly Media, Incorporated)."},{"key":"74599_CR92","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: Fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"74599_CR93","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/ng.3036","volume":"46","author":"A Rimmer","year":"2014","unstructured":"Rimmer, A. et al. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat. Genet 46, 912\u2013918 (2014).","journal-title":"Nat. Genet"},{"key":"74599_CR94","doi-asserted-by":"publisher","unstructured":"Chedom-Fotso, D., Ahmed, A. A., & Yau, C. OncoPhase: Quantification of somatic mutation cellular prevalence using phase information. bioRxiv, 046631. https:\/\/doi.org\/10.1101\/046631 (2016).","DOI":"10.1101\/046631"},{"key":"74599_CR95","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl. Acad. Sci. 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"74599_CR96","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-023-05576-7","volume":"24","author":"J Nulsen","year":"2023","unstructured":"Nulsen, J. et al. Completing a genomic characterisation of microscopic tumour samples with copy number. BMC Bioinforma. 24, 453 (2023).","journal-title":"BMC Bioinforma."},{"key":"74599_CR97","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"74599_CR98","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1093\/bioinformatics\/btu548","volume":"30","author":"A Szolek","year":"2014","unstructured":"Szolek, A. et al. OptiType: precision HLA typing from next-generation sequencing data. Bioinformatics 30, 3310\u20133316 (2014).","journal-title":"Bioinformatics"},{"key":"74599_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"74599_CR100","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1158\/2326-6066.CIR-19-0401","volume":"8","author":"J Hundal","year":"2020","unstructured":"Hundal, J. et al. pVACtools: A computational toolkit to identify and visualize cancer neoantigens. Cancer Immunol. Res 8, 409\u2013420 (2020).","journal-title":"Cancer Immunol. Res"},{"key":"74599_CR101","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.cels.2020.09.001","volume":"11","author":"TJ O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell, T. J., Rubinsteyn, A. & Laserson, U. MHCflurry 2.0: Improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing. Cell Syst. 11, 418\u2013419 (2020).","journal-title":"Cell Syst."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74599-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:01:48Z","timestamp":1787137308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74599-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74599"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74599-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.A.A. is a founder, director, and consultant for Singula Bio Ltd, a founder of Vivo Medica, a consultant for KP Law, and has lectured for AZ and GSK. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8617"}}